Pathophysiology of asthma

Reading File

Finding Sources

Searching PubMed

"asthma"[MeSH Terms] AND "pathophysiology"[MeSH Terms]

Reading File

Finding Sources

Reading File

Loading Image

Reading File

Loading Image

I now have everything needed for a thorough, well-illustrated answer. Here is the full pathophysiology of asthma:

Pathophysiology of Asthma

Asthma is a chronic inflammatory airway disease characterized by variable, reversible airflow obstruction and bronchial hyperresponsiveness. Unlike COPD, it is generally not progressive - but if untreated, it leads to permanent structural change (airway remodeling).

Normal vs. Asthmatic Bronchial Tube - Lippincott Illustrated Reviews: Pharmacology

1. Overview of Airflow Obstruction

The pathophysiologic hallmark is reduction in airway diameter caused by four concurrent processes (Tintinalli's EM):

Mechanism	Description
Smooth muscle contraction	Bronchospasm - the dominant, reversible component
Mucosal edema	Vascular congestion and wall swelling
Mucus hypersecretion	Plugs composed of mucus, serum proteins, inflammatory cells, and cellular debris
Inflammatory cell infiltration	Eosinophils, lymphocytes, mast cells, macrophages, dendritic cells, myofibroblasts

These changes produce increased work of breathing, abnormal pulmonary blood flow distribution, and classic pulmonary function impairment (reduced FEV1, reduced FEV1/FVC ratio, air trapping). - Tintinalli's Emergency Medicine, p. 1345

2. Types of Asthma (Endotypes)

Atopic (Allergic) Asthma - Most Common

Begins in childhood, associated with IgE sensitization to environmental allergens (dust mites, pollen, animal dander, food, mold). A positive family history of atopy, allergic rhinitis, urticaria, or eczema is common.

Nonatopic (Intrinsic) Asthma

Develops in adults, no IgE sensitization (skin tests usually negative). Triggered by viral infections (especially rhinovirus) and airborne irritants (sulfur dioxide, ozone). Associated with chronic rhinosinusitis and nasal polyposis. Less responsive to inhaled glucocorticoids. Driven by innate immune mechanisms via Type 2 Innate Lymphoid Cells (ILC2). - Goldman-Cecil Medicine

Drug-Induced Asthma

Aspirin/NSAIDs (via arachidonic acid shunting toward leukotrienes), beta-blockers.

Neutrophilic/Mixed/Pauci-granulocytic Variants

Less common patterns seen in severe or occupational asthma. - Robbins Basic Pathology

3. Immune Mechanism: The Th2 Pathway

Asthma Pathophysiology - Triggering, Immediate Phase, and Late Phase (Robbins Basic Pathology)

Sensitization Phase

Inhaled antigens are processed by dendritic cells, which present them to naive CD4+ T cells, skewing differentiation toward Th2 cells. Th2 cells then produce:

IL-4 & IL-13 - Drive B cells to produce IgE; IL-13 also independently induces airway hyperresponsiveness and goblet cell metaplasia
IL-5 - Drives eosinophil formation, maturation, recruitment, and survival
Eotaxin - Potent chemoattractant for eosinophils

Secreted IgE binds to high-affinity Fc-epsilon receptors (FcεRI) on submucosal mast cells, "sensitizing" them. - Robbins Basic Pathology, p. 398; Goldman-Cecil Medicine

4. The Two-Wave Inflammatory Response

Early (Immediate) Phase - Within Minutes

On re-exposure to antigen, IgE molecules on mast cell surfaces are cross-linked. Mast cell degranulation releases preformed and newly synthesized mediators:

Mediator	Effect
Histamine	Bronchoconstriction, vasodilation, increased vascular permeability
Leukotrienes C4, D4, E4 (cysteinyl LTs)	Potent, prolonged bronchoconstriction; mucus production
Prostaglandin D2	Bronchoconstriction
Tryptase	Proteolytic damage; promotes airway hyperresponsiveness
TNF-α	Pro-inflammatory amplifier

Bronchospasm is also reinforced by reflex vagal pathways - afferent stimulation of vagal receptors triggers efferent cholinergic bronchoconstriction. - Robbins Basic Pathology, p. 400

Late Phase - 4 to 8 Hours Later

Inflammatory mediators from the early phase stimulate epithelial cells to produce chemokines (including eotaxin), recruiting:

Eosinophils (dominant)
More Th2 cells
Basophils, neutrophils, monocytes

Recruited eosinophils release major basic protein (MBP) and eosinophil cationic protein (ECP), which damage the airway epithelium, expose subepithelial nerve endings, and amplify hyperresponsiveness. This late phase sustains and amplifies inflammation beyond the initial bronchospasm. - Robbins Basic Pathology, p. 402

5. Key Cellular Players

Mast Cells

In mild asthma: MCt type (tryptase only) in the subepithelium
In severe asthma: MCtc type (tryptase + chymase + carboxypeptidase) increases; mast cells infiltrate airway smooth muscle bundles, directly contributing to bronchoconstriction
Activated by IgE cross-linking but also by direct physical stimuli (cold air, exercise, osmotic changes)

Eosinophils

Key effector cells; elevated blood eosinophils are now a biomarker predicting response to inhaled corticosteroids and anti-Th2 biologics
Release MBP, ECP, leukotrienes, and platelet-activating factor (PAF)
Charcot-Leyden crystals (galectin-10 from eosinophils) found in airway mucus serve as a pro-inflammatory factor

T Lymphocytes (Th2)

Orchestrate the entire allergic cascade via IL-4, IL-5, and IL-13

Innate Lymphoid Cells Type 2 (ILC2)

In nonatopic asthma, ILC2 cells stimulated by epithelial "alarmins" (IL-33, TSLP, IL-25) produce IL-5 and IL-13 independent of adaptive immunity - explain why up to 50% of severe asthma patients have T2 inflammation without classical IgE sensitization

Bronchial Epithelium

Not merely a passive barrier - produces pro-inflammatory mediators after injury
Releases alarmins (IL-33, TSLP) that activate ILC2
Abnormal repair drives structural changes
Fishman's Pulmonary Diseases, p. 1136-1137

6. Airway Remodeling - The Chronic Structural Consequence

Repeated cycles of inflammation lead to permanent structural changes collectively called airway remodeling. These begin early (even in childhood) and may precede clinical symptoms:

Change	Description
Subepithelial fibrosis	Thickening of lamina reticularis from collagen types III and IV deposition
Smooth muscle hypertrophy & hyperplasia	Increases bronchospasm potential
Goblet cell hyperplasia	Mucus hypersecretion
Submucosal gland hypertrophy	Further mucus burden
Angiogenesis	New blood vessel formation in airway wall
Airway wall thickening	From edema and cellular infiltration; reduces lumen diameter permanently

Remodeling can become a trigger for non-reversible loss of lung function, increasing asthma severity and mortality. - Washington Manual, p. 5161-5167; Rosen's Emergency Medicine, p. 1683

7. Triggers of Acute Exacerbation

Category	Examples
Allergens	House dust mites, cockroaches, mold, pet dander, pollen
Infections	Rhinovirus (accounts for 40-80% of adult and 80% of pediatric exacerbations); rhinovirus triggers a Th1/neutrophilic response with IL-33 → ILC2 → eosinophil recruitment
Irritants	Tobacco smoke, ozone, NO2, perfumes, cold air
Exercise	Evaporative cooling/hyperosmolarity of airway lining fluid
Occupational	Metal salts, wood dust, isocyanates, biological enzymes
Drugs	Aspirin/NSAIDs, beta-blockers (including eye drops)
Stress	Emotional stress; endocrine factors (estradiol/progesterone fluctuations)
GERD	Micro-aspiration and vagal reflex

8. Genetics

Asthma has ~60% heritability (twin studies). Genome-wide association studies (GWAS) have identified multiple loci, notably:

Chromosome 17q21 - first robust asthma susceptibility locus
Genes encoding the IL-4 receptor, ORMDL3/GSDMB (17q21)
Heritability for bronchial hyperresponsiveness: 30-66%

Environmental-gene interactions (allergen load, pollution, hygiene hypothesis - microbial exposure in early life suppressing atopic expression) shape disease phenotype. - Rosen's Emergency Medicine, p. 1687

9. Pulmonary Function Consequences

Reduced FEV1 and FEV1/FVC ratio (obstructive pattern)
Air trapping - increased residual volume
Obstruction is worst on expiration (dynamic airway collapse), making expiration effortful and fatiguing
Hyperinflation from incomplete emptying
Severe obstruction = silent chest (absent wheeze due to minimal airflow)
Reversibility with bronchodilators is the diagnostic hallmark

Summary Diagram of Mechanism

Allergen exposure
      ↓
Dendritic cell → Th2 differentiation
      ↓
IL-4/IL-13 → IgE production by B cells
      ↓
IgE binds Fc receptors on MAST CELLS
      ↓
Re-exposure → IgE cross-linking → Degranulation
      ↓
EARLY PHASE (minutes): Histamine, LTC4/D4/E4, PGD2
→ Bronchoconstriction + vasodilation + mucus
      ↓
LATE PHASE (4-8 hrs): Chemokines, Eotaxin
→ Eosinophil, Th2 cell, basophil recruitment
→ MBP/ECP → Epithelial damage + hyperresponsiveness
      ↓
CHRONIC: Airway remodeling (fibrosis, hypertrophy, angiogenesis)

Sources:

Robbins & Kumar Basic Pathology, pp. 387-428
Goldman-Cecil Medicine, pp. 2151-2166
Washington Manual of Medical Therapeutics, pp. 5147-5198
Tintinalli's Emergency Medicine, pp. 1343-1354
Rosen's Emergency Medicine, pp. 1677-1688
Fishman's Pulmonary Diseases and Disorders, pp. 1126-1136
Lippincott Illustrated Reviews: Pharmacology, p. 1389

This is a shared conversation. Sign in to Orris to start your own chat.